📝 Archit Organosys Ltd — results explained
Quarter ended March 2024 (Q4 FY24)
Archit Organosys Ltd reported revenue of ₹31 crore for the quarter ended March 2024 (Q4 FY24), down 33.4% from ₹47 crore in the same quarter last year, and up 24.9% sequentially over the December 2023 quarter.
Net profit fell 7.7% year-on-year to ₹2 crore, from ₹2 crore. Earnings per share (EPS) came in at ₹0.87.
Operating profit stood at ₹-0 crore — an operating margin (OPM) of -0.5%, compared with 6.3% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY24, Archit Organosys Ltd posted revenue of ₹113 crore, a decline of 11.4% over FY23, with a net profit of ₹3 crore (down 71.2% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹113 crore with a net profit of ₹3 crore.
Valuation snapshot
At the current price of ₹66.11, 524640 has a market capitalisation of ₹139 crore and a trailing P/E of about 42.5.
Within the Commodity Chemicals industry, it is the 16th-largest of the 50 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 65.88%, public shareholders 34.11% of Archit Organosys Ltd.